Delivery Order SPE2DR25D2010-SPE2DR26F4ZLE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical. This competitive, non-set-aside contract is valued at $3,312.12 with a firm fixed price structure and an ultimate completion date of December 8, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $2,183.09 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units on December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $6,013.44 delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Lidocaine 5% patches (30-count units). This non-set-aside, competitively awarded contract reflects firm fixed pricing and is scheduled for completion by November 14, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $15,730.77 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with performance in Conshohocken, Pennsylvania and an ultimate completion date of November 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation, reflecting the contractor's proven capability to meet federal pharmaceutical procurement requirements through open competition. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $1,730.32 to AmerisourceBergen Drug Corp for 30 units of Lidocaine 5% Patch. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The ultimate completion date is December 15, 2025, with the award issued on December 12, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $20,535.06 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain relief medication. The contract is a firm fixed price delivery order with an ultimate completion date of November 18, 2025, and was competitively awarded without any set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $19,570.26 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This firm fixed price contract was competitively awarded without set-aside designation and carries an ultimate completion date of August 19, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office operations in Conshohocken, Pennsylvania, which serves as the company's headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $2,161.28 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. The contract, awarded on July 23, 2025, with completion scheduled for July 24, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $1,362.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count packages of Lidocaine 5% Patch on September 26, 2025, with an ultimate completion date of September 29, 2025. This non-set-aside contract was competitively awarded to support federal medical supply requirements. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,143.84 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Lidocaine 5% Patch 30S, a topical anesthetic medication commonly used for localized pain relief. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 18, 2025, with fulfillment through AmerisourceBergen's operations in Conshohocken, Pennsylvania. The award includes no set-aside designation, reflecting...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4ZLEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,107.33 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. The contract, issued on December 29, 2025, with an ultimate completion date of December 30, 2025, carries firm fixed price terms with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide. AmerisourceBergen's established federal contract portfolio demonstrates substantial capability in delivering diverse pharmaceutical products to the Defense Health Agency and other government healthcare systems through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/28/25 |